Provided by Tiger Trade Technology Pte. Ltd.

Protagonist Therapeutics

87.39
+0.80000.92%
Post-market: 87.390.00000.00%16:12 EST
Volume:668.55K
Turnover:58.89M
Market Cap:5.46B
PE:132.41
High:89.59
Open:86.72
Low:86.00
Close:86.59
52wk High:96.54
52wk Low:33.70
Shares:62.52M
Float Shares:43.15M
Volume Ratio:1.37
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6600
EPS(LYR):4.23
ROE:7.80%
ROA:1.82%
PB:8.46
PE(LYR):20.66

Loading ...

Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jul 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Major Issues Report

Form 8-K - Current report